Trimetazidine Hydrochloride in pharma franchise in Tripura

Trimetazidine Hydrochloride in PCD pharma franchise in Gangtok

Trimetazidine Hydrochloride in top pharma company in Jaipu

Trimetazidine Hydrochloride in pcd pharma supplier in Meerut

Trimetazidine Hydrochloride in phama franchise company in India
Trimetazidine Hydrochloride in phama distributor in Bharatpur

Home/Products /trimetazidine-hydrochloride-i-point-p-point-35mg-tablets-tablet

Trizapime 35 MR Tablet

Composition : Trimetazidine Hydrochloride I.P. 35mg Tablets

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹135/-

Trizapime is a specialized pharmaceutical formulation containing Trimetazidine Hydrochloride, primarily used in the management of angina pectoris and other cardiovascular conditions. Trimetazidine works by improving the efficiency of energy metabolism in heart cells, thereby reducing the heart's oxygen demand, especially during periods of stress. This helps to maintain normal heart function and alleviates chest pain and discomfort associated with angina.

Trizapime is commonly prescribed for patients with chronic stable angina to reduce the frequency and severity of angina attacks. It can also be used in combination with other cardiovascular medications for a more comprehensive approach to managing heart disease. The medication works by ensuring that the heart’s cells can maintain their energy production in the face of reduced oxygen, improving overall cardiac performance.

Trizapime is well-tolerated by most patients and is generally considered safe when used as directed by a healthcare provider. It is available in tablet form, making it convenient for both outpatient and long-term care treatments. The recommended dosage is typically 35 mg once or twice daily, depending on the severity of the condition and as prescribed by a healthcare professional.

Read More

About the Product

Trizapime is a specialized pharmaceutical formulation containing Trimetazidine Hydrochloride, primarily used in the management of angina pectoris and other cardiovascular conditions. Trimetazidine works by improving the efficiency of energy metabolism in heart cells, thereby reducing the heart's oxygen demand, especially during periods of stress. This helps to maintain normal heart function and alleviates chest pain and discomfort associated with angina.

Trizapime is commonly prescribed for patients with chronic stable angina to reduce the frequency and severity of angina attacks. It can also be used in combination with other cardiovascular medications for a more comprehensive approach to managing heart disease. The medication works by ensuring that the heart’s cells can maintain their energy production in the face of reduced oxygen, improving overall cardiac performance.

Trizapime is well-tolerated by most patients and is generally considered safe when used as directed by a healthcare provider. It is available in tablet form, making it convenient for both outpatient and long-term care treatments. The recommended dosage is typically 35 mg once or twice daily, depending on the severity of the condition and as prescribed by a healthcare professional.

Possible side effects include dizziness, nausea, headache, gastrointestinal disturbances, or allergic reactions. Consult a healthcare provider if side effects persist.

Trizapime is indicated for the management of chronic stable angina and to improve the functional capacity of patients with angina pectoris.

Use Trizapime only as directed by a healthcare professional. Do not exceed the recommended dose. Discontinue use if allergic reactions occur and consult your doctor.

Store in a cool, dry place at 15°C to 30°C, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation